giovedì 29 gennaio 2009
Fourth ventricular ependymoma with foramen of Luschka & Magendie extension
CT paranasal sinuses: Normal sinuses. Incidental note of ventricular dilatation. Partial visualization of 4th ventricular mass.
MRI Brain: Abnormal heterogeneously enhancing mass within the posterior fossa, potentially arising from the floor of the fourth ventricle and causing moderate obstructive hydrocephalus. Lobular extension of tumor via the bilateral (left > right) foramen of Luschka and foramen of Magendie.
- Atypical teratoid/rhabdoid tumor
- Cerebellar pilocytic astrocytoma
Diagnosis: Fourth ventricular ependymoma with foramen of Luschka & Magendie extension masquerading as sinusitis
Arising from the ependymal lining of the ventricles, ependymomas constitute one-tenth of primary CNS tumors in children. 90 percent of the tumors are intracranial which helps ependymomas rank number three among pediatric brain tumors. The majority of the intracranial epenymomas are infratentorial (about two-thirds). The remaining one-third of the intracranial variety are found around the periventricular white matter.
An equal distribution has been reported in males and females. No known race predilection noted. The mean age of diagnosis is 5 to 6 years of age. The clinical presentation is often non-specific. However, it is usually related to increased intracranial pressure. The classic triad (if present) includes morning headache, relieved by vomiting and improvement with progression of the day. Other signs/symptoms can include irritability, gait problems, fatigue, personality change and declining performance at school.
Gross total surgical resection and radiation therapy are the mainstays of treatment. The fiver year rate of survival is estimated close to 55 percent. Poorer outcomes have been reported in children with incomplete resection. The exact role of chemotherapy is still under investigation.
Radiologic overview of the diagnosis
CT and MRI are the primary modalities for imaging brain tumors in children. A CT may be obtained initially. However, MRI with contrast is more useful for component characterization and tumor extension.
Regardless of imaging modality, the best diagnostic clues include inhomogeneous appearance and pliability. The tumor is known for its ability to squeeze through the fourth ventricle into the cisterns. Another important diagnostic feature is ill defined interface with the floor of the fourth ventricle.
On CT, calcifications are present in half of these tumors. Cystic and hemorrhagic components can also be seen. With fourth ventricular tumors, hydrocephalus can be present. The enhancement pattern is typically heterogeneous.
On MRI, an inhomogeneous appearance persists with T1 isointensity to hypointensity. The tumor is isointense to hyperintense of T2 weighted images. Areas with calcification or blood products are T1 hyperintense and T2 hypointense. On gradient images, the calcification demonstrates blooming artifact. The post contrast enhancement pattern remains inhomogeneous with overall mild to moderate enhancement. High quality sagital sequences should be included in the MRI protocol. A sagital image can help identify the point of origin (floor of fourth ventricle = ependymoma, roof of fourth ventricle = medulloblastoma). MR spectroscopy cannot reliably differentiate between this and other tumors. However, lactate and choline peak elevation is present with decrease in NAA.